Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans
Diabetes Care - United States
doi 10.2337/dc10-1677
Full Text
Open PDFAbstract
Available in full text
Date
January 7, 2011
Authors
Publisher
American Diabetes Association